The information contained in this section of Isofol Medical AB (publ)’s website is restricted and is not for release, publication or distribution, directly or indirectly, in whole or in part, in or into the United States, Australia, Belarus, Hong Kong, Japan, Canada, New Zealand, Russia, Singapore, South Africa, South Korea, Switzerland or any jurisdiction in which such release, publication or distribution would be unlawful or would require registration or other measures besides those required under Swedish law.
Isofol invites investors, shareholders, and other stakeholders to an Investor & Scientific Update in Stockholm on November 12 and Gothenburg November 13.
Agenda and registration >>